Efficacy and Safety of Pioglitazone versus Glimepiride after Metformin and Alogliptin Combination Therapy: A Randomized, Open-Label, Multicenter, Parallel-Controlled Study
Jeong Mi Kim (Kim JM), Sang Soo Kim (Kim SS), Jong Ho Kim (Kim JH), Mi Kyung Kim (Kim MK), Tae Nyun Kim (Kim TN), Soon Hee Lee (Lee SH), Chang Won Lee (Lee CW), Ja Young Park (Park JY), Eun Sook Kim (Kim ES), Kwang Jae Lee (Lee KJ), Young Sik Choi (Choi YS), Duk Kyu Kim (Kim DK), In Joo Kim (Kim IJ)
Diabetes Metab J. 2020;44(1):67-77.   Published online 2019 Jul 11     DOI: https://doi.org/10.4093/dmj.2018.0274
Citations to this article as recorded by Crossref logo
Glycaemic control with add‐on thiazolidinedione or a sodium‐glucose co‐transporter‐2 inhibitor in patients with type 2 diabetes after the failure of an oral triple antidiabetic regimen: A 24‐week, randomized controlled trial
Jaehyun Bae, Ji Hye Huh, Minyoung Lee, Yong‐Ho Lee, Byung‐Wan Lee
Diabetes, Obesity and Metabolism.2021; 23(2): 609.     CrossRef
Development and validation of a sensitive LC-MS/MS method for pioglitazone: application towards pharmacokinetic and tissue distribution study in rats
Kusuma Kumari G., Praveen Thaggikuppe Krishnamurthy, Ravi Kiran Ammu V. V. V., Kurawattimath Vishwanath, S. T. Narenderan, B. Babu, Nagappan Krishnaveni
RSC Advances.2021; 11(19): 11437.     CrossRef